Ethics code: N/A
Clinical trials code: N/A
Department of Psychiatry, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract: (181 Views)
Fibromyalgia (FM), a complex chronic pain syndrome affecting 5% of the global population, has a multifactorial etiology involving genetic, neuroendocrine, and environmental factors. The COVID-19 pandemic has brought new insights into FM, with emerging evidence showing that COVID-19 survivors may develop FM-like symptoms. It raises the possibility of an overlap with post-viral syndromes. Studies indicate that nearly one-third of post-COVID patients meet FM criteria, with factors like obesity and male gender influencing susceptibility. Additionally, the heightened anxiety associated with COVID-19 exacerbates FM symptoms, suggesting the role of psychological stress. Recognizing FM in the context of long-term COVID-19 can enlighten treatment strategies, particularly with insights from rheumatology, which may enhance disease outcomes. This research intersection underscores an urgent need for comprehensive studies to clarify the impact of viral infections on chronic pain syndromes, potentially refining the management and classification of FM.
Type of Study:
Letter to Editor |
Subject:
Health Received: 2024/10/2 | Accepted: 2024/04/1 | Published: 2024/04/1